Related Experiment Videos

Susceptibility of ampicillin-resistant Haemophilus influenzae to seven penicillins

Insights

Most clinical Haemophilus influenzae isolates resistant to ampicillin produce beta-lactamase. Ticarcillin and carbenicillin showed the greatest activity against these bacteria, though clinical utility remains unproven.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Haemophilus influenzae is a significant human pathogen.
  • Antibiotic resistance, particularly to ampicillin, is a growing concern.
  • Beta-lactamase production is a common mechanism of resistance.

Purpose of the Study:

  • To evaluate the susceptibility of clinical Haemophilus influenzae isolates to various penicillins.
  • To determine the prevalence of beta-lactamase production in ampicillin-resistant strains.
  • To compare the in vitro activity of different beta-lactam antibiotics.

Main Methods:

  • Testing 67 clinical isolates of Haemophilus influenzae from the US, UK, and Germany.
  • Assessing susceptibility to penicillin, ampicillin, amoxicillin, epicillin, carbenicillin, ticarcillin, and methicillin.
  • Detecting beta-lactamase production in ampicillin-resistant and susceptible strains.
  • Determining minimal inhibitory concentrations (MICs) for comparative analysis.

Main Results:

  • 53 of 67 isolates were ampicillin-resistant; 14 were ampicillin-susceptible.
  • Beta-lactamase was produced by 52 of the 53 ampicillin-resistant strains.
  • None of the ampicillin-susceptible strains produced beta-lactamase.
  • Ticarcillin and carbenicillin demonstrated the highest activity based on MICs.

Conclusions:

  • Beta-lactamase production is strongly associated with ampicillin resistance in clinical Haemophilus influenzae isolates.
  • Ticarcillin and carbenicillin exhibit potent in vitro activity against these strains.
  • Further clinical studies are needed to establish the therapeutic value of ticarcillin and carbenicillin.

Related Concept Videos